Hiroshi Onimaru Selected Research

Hiroshi Onimaru Research Topics

5	Hypoxia (Hypoxemia) 03/2022 - 02/2013
4	Respiratory Insufficiency (Respiratory Failure) 05/2016 - 02/2005
2	Hypercapnia 01/2021 - 04/2012
1	Hyperoxia 03/2022
1	Asphyxia (Suffocation) 03/2022
1	Hypertension (High Blood Pressure) 01/2017
1	Perinatal Death 02/2013
1	Sudden Infant Death (SID) 02/2013
1	Respiratory Acidosis 04/2006
1	Acidosis 04/2006

1	Oxygen (Dioxygen)IBA 03/2022
1	Transient Receptor Potential ChannelsIBA 03/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022
1	NADP (NADPH)IBA 03/2022
1	CalciumIBA 01/2021
1	TRPA1 Cation ChannelIBA 01/2021
1	Erythropoietin FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018
1	IncretinsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Lidocaine (Xylocaine)FDA LinkGeneric 05/2016
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2013
1	SolutionsIBA 04/2012
1	Propofol (Diprivan)FDA LinkGeneric 03/2011
1	Potassium Channels (Potassium Channel)IBA 04/2006
1	Tetrodotoxin (Tetradotoxin)IBA 04/2006
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 04/2006
1	CannabinoidsIBA 12/2005
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 12/2005
1	BicucullineIBA 12/2005
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2005
1	Cannabinoid Receptor AgonistsIBA 12/2005
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 02/2005